Barclays Increases Sherwin-Williams (NYSE:SHW) Price Target to $370.00

Sherwin-Williams (NYSE:SHW) had its price objective increased by research analysts at Barclays from $355.00 to $370.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective would suggest a potential upside of 2.33% from the stock’s previous close.

Several other research analysts have also recently commented on SHW. UBS Group reissued an “underperform” rating on shares of Sherwin-Williams in a research note on Friday, October 18th. Wells Fargo & Company raised their target price on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a report on Tuesday, October 15th. Robert W. Baird boosted their price target on shares of Sherwin-Williams from $350.00 to $360.00 and gave the stock a “neutral” rating in a report on Wednesday. Jefferies Financial Group raised their price objective on shares of Sherwin-Williams from $392.00 to $415.00 and gave the company a “buy” rating in a report on Monday, August 26th. Finally, Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research note on Thursday, July 18th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $395.29.

Sherwin-Williams Stock Down 0.3 %

Sherwin-Williams stock opened at $361.59 on Wednesday. The company has a market capitalization of $91.68 billion, a PE ratio of 38.55, a price-to-earnings-growth ratio of 2.87 and a beta of 1.17. The company has a debt-to-equity ratio of 1.97, a quick ratio of 0.50 and a current ratio of 0.83. Sherwin-Williams has a fifty-two week low of $232.06 and a fifty-two week high of $392.57. The firm has a 50 day moving average price of $371.81 and a 200 day moving average price of $334.64.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings data on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing analysts’ consensus estimates of $3.56 by ($0.19). Sherwin-Williams had a net margin of 11.09% and a return on equity of 74.45%. The business had revenue of $6.16 billion during the quarter, compared to analyst estimates of $6.20 billion. During the same quarter last year, the firm posted $3.20 EPS. The company’s revenue for the quarter was up .7% on a year-over-year basis. Research analysts expect that Sherwin-Williams will post 11.31 earnings per share for the current year.

Insider Activity

In related news, CFO Allen J. Mistysyn sold 14,520 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the transaction, the chief financial officer now directly owns 63,520 shares of the company’s stock, valued at $23,301,041.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Sherwin-Williams

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. HHM Wealth Advisors LLC grew its holdings in Sherwin-Williams by 102.3% during the second quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 45 shares during the period. Semmax Financial Advisors Inc. increased its holdings in shares of Sherwin-Williams by 136.4% in the 2nd quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 60 shares in the last quarter. VitalStone Financial LLC lifted its stake in shares of Sherwin-Williams by 233.3% in the second quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 77 shares during the period. GHP Investment Advisors Inc. boosted its holdings in Sherwin-Williams by 47.5% during the third quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 28 shares in the last quarter. Finally, Anfield Capital Management LLC purchased a new stake in Sherwin-Williams during the second quarter worth about $38,000. Institutional investors and hedge funds own 77.67% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.